50-112-3969

IRF8 Monoclonal Antibody (V3GYWCH), PerCP-eFluor™ 710, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-112-3969-Each-of-1 In Stock ₹ 37,736.00

50-112-3969 - Each of 1

₹ 37,736.00

In Stock

Quantity

1

Base Price: ₹ 37,736.00

GST (18%): ₹ 6,792.48

Total Price: ₹ 44,528.48

Antigen

IRF8

Classification

Monoclonal

Concentration

0.2 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

P23611, Q02556

Gene Symbols

Irf8

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

15900, 3394

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

V3GYWCH

Conjugate

PerCP-eFluor 710

Gene

Irf8

Gene Alias

AI893568; H-ICSBP; Icsbp; Icsbp1; IMD32A; IMD32B; interferon consensus sequence binding protein 1; Interferon consensus sequence-binding protein; Interferon regulatory factor 8; Irf8; IRF-8; Myls; transcription factor ICSBP

Host Species

Mouse

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

39-880-0

--

Img

Invitrogen

50-112-3976

--

Img

Invitrogen

50-112-3895

--

Img

Invitrogen

50-112-3890

--

Img

Invitrogen

50-112-2247

--

Img

Invitrogen

46-592-182

--

Img

Invitrogen

50-112-3953

--

Img

Invitrogen

46-105-182

--

Description

  • Description: The V3GYWCH monoclonal antibody reacts with human and mouse interferon regulatory factor 8 (IRF8; ICSBP)
  • IRF8 is a 50 kDa transcription factor that plays a critical role in the development of dendritic cells (DC)
  • Specifically, IRF8 is essential in the development and differentiation of plasmacytoid DC (pDC) and CD8a+ DC
  • IRF8-/- mice are deficient in both pDC and CD8a+ DC populations
  • CD8a- DC are present in normal numbers in IRF8-/- mice but fail to mature upon Toll-like receptor signaling and are functionally impaired in response to in vivo microbial stimulation
  • IRF8 deficiency does not affect the frequency or viability of DC precursors and as a result retroviral IRF8 transduction restores pDC development from DC progenitors in IRF8-/- mice
  • Applications Reported: This V3GYWCH antibody has been reported for use in intracellular staining followed by flow cytometric analysis
  • Applications Tested: This V3GYWCH antibody has been tested by intracellular staining and flow cytometric analysis of normal human peripheral blood cells using the Foxp3/Transcription Factor Staining Buffer Set (cat
  • 00-5523) and protocol
  • Please refer to Best Protocols: Protocol B: One-step protocol: intracellular (nuclear) proteins located under the Resources Tab online
  • This can be used at less than or equal to 0.5 μg per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • IRF8 (interferon regulatory factor 8) is a transcriptional activator or repressor
  • It specifically binds to the upstream regulatory region of type I IFN and IFN-inducible MHC class I genes
  • IRF8 plays a negative regulatory role in cells of the immune system
  • It is involved in CD8+ dendritic cell differentiation by forming a complex with the BATF-JUNB heterodimer in immune cells
  • This leads to recognition of AICE sequence, an immune-specific regulatory element, followed by cooperative binding of BATF and IRF8 and activation of the genes
  • Mutations in the gene can result in immunodeficiencey 32A and 32B.